BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

584 related articles for article (PubMed ID: 15294012)

  • 1. Economic aspects of severe sepsis: a review of intensive care unit costs, cost of illness and cost effectiveness of therapy.
    Burchardi H; Schneider H
    Pharmacoeconomics; 2004; 22(12):793-813. PubMed ID: 15294012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost analysis of Omega-3 supplementation in critically ill patients with sepsis.
    Kyeremanteng K; Shen J; Thavorn K; Fernando SM; Herritt B; Chaudhuri D; Tanuseputro P
    Clin Nutr ESPEN; 2018 Jun; 25():63-67. PubMed ID: 29779820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct costs of severe sepsis in three German intensive care units based on retrospective electronic patient record analysis of resource use.
    Moerer O; Schmid A; Hofmann M; Herklotz A; Reinhart K; Werdan K; Schneider H; Burchardi H
    Intensive Care Med; 2002 Oct; 28(10):1440-6. PubMed ID: 12373469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Economic burden of illness imposed by severe sepsis in Austria.
    Schmid A; Schneider H; Adlof A; Smolle KH; Edelmann G; Sporn P; Frass M; Sumann G; Koller W; Schobersberger W
    Wien Klin Wochenschr; 2002 Aug; 114(15-16):697-701. PubMed ID: 12602114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The incidence and cost of severe sepsis in intensive care units].
    Csomós A; Hoffer G; Fülesdi B; Ludwig E
    Orv Hetil; 2005 Jul; 146(29):1543-7. PubMed ID: 16136776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A German national prevalence study on the cost of intensive care: an evaluation from 51 intensive care units.
    Moerer O; Plock E; Mgbor U; Schmid A; Schneider H; Wischnewsky MB; Burchardi H
    Crit Care; 2007; 11(3):R69. PubMed ID: 17594475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of a standardized PCT-algorithm reduces costs in intensive care in septic patients - a DRG-based simulation model.
    Wilke MH; Grube RF; Bodmann KF
    Eur J Med Res; 2011 Dec; 16(12):543-8. PubMed ID: 22112361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Economic Evaluation of Telemedicine for Patients in ICUs.
    Yoo BK; Kim M; Sasaki T; Melnikow J; Marcin JP
    Crit Care Med; 2016 Feb; 44(2):265-74. PubMed ID: 26540398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cost differences in the treatment of severe sepsis between survivors and non-survivors on the first day of intensive care admission].
    Csomós A; Szentkereszty Z; Fülesdi B
    Orv Hetil; 2007 Sep; 148(39):1851-6. PubMed ID: 17890173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Burden of illness imposed by severe sepsis in Switzerland.
    Schmid A; Pugin J; Chevrolet JC; Marsch S; Ludwig S; Stocker R; Finnern H
    Swiss Med Wkly; 2004 Feb; 134(7-8):97-102. PubMed ID: 15106026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The costs of septic syndromes in the intensive care unit and influence of hospital-acquired sepsis.
    Brun-Buisson C; Roudot-Thoraval F; Girou E; Grenier-Sennelier C; Durand-Zaleski I
    Intensive Care Med; 2003 Sep; 29(9):1464-71. PubMed ID: 12856120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of drotrecogin alfa (activated) for the treatment of severe sepsis in Germany.
    Neilson AR; Burchardi H; Chinn C; Clouth J; Schneider H; Angus D
    J Crit Care; 2003 Dec; 18(4):217-27. PubMed ID: 14691895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A multicentre, prospective study to evaluate costs of septic patients in Brazilian intensive care units.
    Sogayar AM; Machado FR; Rea-Neto A; Dornas A; Grion CM; Lobo SM; Tura BR; Silva CL; Cal RG; Beer I; Michels V; Safi J; Kayath M; Silva E;
    Pharmacoeconomics; 2008; 26(5):425-34. PubMed ID: 18429658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Economics and outcome in the intensive care unit.
    Pittoni GM; Scatto A
    Curr Opin Anaesthesiol; 2009 Apr; 22(2):232-6. PubMed ID: 19390250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A method to determine hospital costs associated with nosocomial infections].
    Gianino MM; Vallino A; Anselmo E; Minniti D; Abbona F; Mineccia C; Silvaplana P; Zotti CM
    Ann Ig; 2007; 19(4):381-92. PubMed ID: 17937330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost effectiveness of drotrecogin alfa (activated) for the treatment of severe sepsis in the United Kingdom.
    Davies A; Ridley S; Hutton J; Chinn C; Barber B; Angus DC
    Anaesthesia; 2005 Feb; 60(2):155-62. PubMed ID: 15644013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The patient-related costs of care for sepsis patients in a United Kingdom adult general intensive care unit.
    Edbrooke DL; Hibbert CL; Kingsley JM; Smith S; Bright NM; Quinn JM
    Crit Care Med; 1999 Sep; 27(9):1760-7. PubMed ID: 10507595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Impact of Palliative Care Consultation in the ICU on Length of Stay: A Systematic Review and Cost Evaluation.
    Kyeremanteng K; Gagnon LP; Thavorn K; Heyland D; D'Egidio G
    J Intensive Care Med; 2018 Jun; 33(6):346-353. PubMed ID: 27582396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of reducing intensive care unit length of stay on hospital costs: evidence from a tertiary care hospital in Canada.
    Evans J; Kobewka D; Thavorn K; D'Egidio G; Rosenberg E; Kyeremanteng K
    Can J Anaesth; 2018 Jun; 65(6):627-635. PubMed ID: 29476403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes and healthcare-associated costs one year after intensive care-treated cardiac arrest.
    Efendijev I; Folger D; Raj R; Reinikainen M; Pekkarinen PT; Litonius E; Skrifvars MB
    Resuscitation; 2018 Oct; 131():128-134. PubMed ID: 29958958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.